First ever potential treatment for Multiple System Atrophy - Dr. Nicolas Phielipp, MD 

Link to article: regenmedglobal.com/article/8f...
Welcome to Regenmedglobal The Podcast. In this podcast, we discuss a first ever potential treatment for Multiple System Atrophy - Parkinson's type (MSA-P) using GDNF gene therapy in clinical trials. Leading this research we have Dr. Nicolas Phielipp, MD, Associate Professor of Neurology at UC Irvine School of Medicine.
Link to clinical trial: classic.clinicaltrials.gov/ct...
0:00- Introduction
0:28- Dr. Phielipp’s background as principal investigator of the clinical trial
1:07-What is this GDNF gene therapy treatment for the clinical trial?
2:39- is this the first time we are ever utilizing this treatment, or has it been used before?
3:26- are there any treatments out there for multiple system atrophy?
4:10- overview of clinical trial
6:10- what kind of outcomes do you expect to see from this clinical trial?
7:05- what are the potential risks?
8:27- has anyone gone through the procedure for MSA?
9:00- who would be considered an ideal candidate?
9:58- how soon can we know if something like this could be effective?
11:04- when are the results expected for Phase 1 clinical trials?
12:11- why is potential treatment so important?
13:21- what metrics would you like at to identify success?
14:40- Finishing thoughts
#parkinson #parkinsonsdisease #neurologicaldisorders
-neurology - movement disorder - neurodegenerative disease - MSA -